Combined modality therapy for rectal cancer: The relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence

Annals of Surgical Oncology

Volumn 19, Issue 8, 2012, Pages 2471-2476

  Song, Suisui ^a   Hong, Julian C ^b   McDonnell, Siobhan E ^b   Koong, Albert C ^b   Minsky, Bruce D ^a   Chang, Daniel T ^b   Liauw, Stanley L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROURACIL; OXALIPLATIN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREDICTIVE VALUE; RADIATION DOSE; RECTUM CANCER; TREATMENT FAILURE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865007570     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2266-x     Document Type: Article

References (21)

1. GY Locker S Hamilton J Harris, et al. 2006 ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol. 24 5313 5327 17060676 10.1200/JCO.2006.08.2644 1:CAS:528: DC%2BD28XhtlemurfN
2. HJ Wanebo B Rao CM Pinsky, et al. 1978 Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer N Engl J Med. 299 448 451 683276 10.1056/NEJM197808312990904 1:STN:280:DyaE1c3ks12htA%3D%3D
3. MJ Goldstein EP Mitchell 2005 Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest. 23 338 351 16100946 10.1081/CNV-58878
4. J Boey HC Cheung CK Lai J Wong 1984 A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma World J Surg. 8 279 286 6464483 10.1007/BF01655052 1:STN:280: DyaL2c3ns1altw%3D%3D
5. K Slentz A Senagore J Hibbert WP Mazier TM Talbott 1994 Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg. 60 528 531 8010568 1:STN:280:DyaK2c3nvF2nuw%3D%3D
6. JK Lin CC Lin SH Yang, et al. 2011 Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer Int J Colorectal Dis. 26 1135 1141 21538056 10.1007/s00384-011-1209-5
7. JM Berman RJ Cheung DS Weinberg 2000 Surveillance after colorectal cancer resection Lancet. 355 9201 395 399 10665570 10.1016/S0140-6736(99)06552-6 1:STN:280:DC%2BD3c7islegtA%3D%3D
8. R Sauer H Becker W Hohenberger, et al. 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med. 351 1731 1740 15496622 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D
9. C Aschele S Lonardi 2007 Multidisciplinary treatment of rectal cancer: medical oncology Ann Oncol. 18 1908 1915 18198494 10.1093/annonc/mdm478 1:STN:280:DC%2BD1c%2FksVKhtw%3D%3D
10. C Rodel P Martus T Papadoupolos, et al. 2005 Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol. 23 8688 8696 16246976 10.1200/JCO.2005.02.1329
11. R Glynne-Jones S Mawdsley JR Novell 2006 The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language Colorectal Dis. 8 800 807 17032329 10.1111/j.1463-1318.2006.01139.x 1:STN:280: DC%2BD28ngtVOkug%3D%3D
12. L Topova G Hellmich E Puffer, et al. 2011 Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma Dis Colon Rectum. 54 401 411 21383559 10.1007/DCR.0b013e3182070efb
13. E Tan N Gouvas RJ Nicholls P Ziprin E Xynos PP Tekkis 2009 Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer Surg Oncol. 18 15 24 18619834 10.1016/j.suronc.2008.05.008
14. I Iwanicki-Caron F Di Fiore I Roque, et al. 2008 Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer J Clin Oncol. 26 3681 3686 18669452 10.1200/JCO.2007.15.0904
15. WS Wang JK Lin TC Lin, et al. 2001 Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer Int J Colorectal Dis. 16 96 101 11355325 10.1007/s003840000266 1:STN:280:DC%2BD3M3mtlCnuw%3D%3D
16. RO Perez GP Sao Juliao A Habr-Gama, et al. 2009 The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer Dis Colon Rectum. 52 1137 1143 19581858 10.1007/DCR.0b013e31819ef76b
17. S Ishihara T Watanabe T Kiyomatsu K Yasuda H Nagawa 2010 Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer Int J Colorectal Dis. 25 1417 1425 20809426 10.1007/s00384-010-1051-1
18. JW Park SB Lim DY Kim, et al. 2009 Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery Int J Radiat Oncol Biol Phys. 74 810 817 19101093 10.1016/j.ijrobp.2008.08.057
19. NY Jang SB Kang DW Kim, et al. 2011 The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer Dis Colon Rectum. 54 245 252 21228676 10.1007/DCR.0b013e3181fcee68
20. AG Renehan M Egger MP Saunders ST O'Dwyer 2002 Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials BMJ. 324 7341 813 11934773 10.1136/bmj.324.7341.813
21. A Figueredo RB Rumble J Maroun, et al. 2003 Follow-up of patients with curatively resected colorectal cancer: a practice guideline BMC Cancer. 3 26 14529575 10.1186/1471-2407-3-26